COMPARISON OF THE POSTANTIBIOTIC AND POSTANTIBIOTIC SUB-MIC EFFECTS OF LEVOFLOXACIN AND CIPROFLOXACIN ON STAPHYLOCOCCUS-AUREUS AND STREPTOCOCCUS-PNEUMONIAE
L. Licata et al., COMPARISON OF THE POSTANTIBIOTIC AND POSTANTIBIOTIC SUB-MIC EFFECTS OF LEVOFLOXACIN AND CIPROFLOXACIN ON STAPHYLOCOCCUS-AUREUS AND STREPTOCOCCUS-PNEUMONIAE, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 950-955
The postantiobiotic subminimum inhibitory concentration effect (PA SME
) may simulate in vivo drug exposure more accurately than the postanti
biotic effect (PAE) since subinhibitory concentrations of drug persist
between antibiotic dosings. In this study, we compared the PAEs and P
A SMEs of levofloxacin and ciprofloxacin for clinical isolates of fluo
roquinolone-susceptible Staphylococcus aureus and Streptococcus pneumo
niae. At two times the MIC, PAEs of levofloxacin were an average of 0.
6 h longer than the PAEs obtained for ciprofloxacin for methicillin-su
sceptible and methicillin-resistant S. aureus strains. The PAEs of lev
ofloxacin and ciprofloxacin ranged from 1.8 to 3.1 and 1.1 to 2.4 h, r
espectively. Continued exposure of the methicillin-resistant strain to
1/16, 1/8, and 1/4 the MIC resulted in PA SMEs of 6.5, 15.3, and >22.
3 h, respectively, for levofloxacin and 3.8, 8.0, and 12.3 h, respecti
vely, for ciprofloxacin. For isolates of S. pneumoniae, at two times t
he MIC of both fluoroquinolones, the average PAEs of levofloxacin and
ciprofloxacin were equivalent: 1.3 h for the penicillin-susceptible is
olate and 0.6 h for the penicillin-resistant isolate. Continued exposu
re of the penicillin-susceptible S. pneumoniae strain to 1/16, 1/8, an
d 1/4 the MIC resulted in average PA SMEs of 1.0, 1.4, and 2.8 h, resp
ectively, for levofloxacin and 1.8, 2.0, and 2.5 h, respectively, for
ciprofloxacin. Continued exposure of penicillin-resistant S. pneumonia
e to 1/16, 1/8, and 1/4 the MIC of the same fluoroquinolones resulted
in average PA SMEs of 0.6, 1.1, and 2.9 h, respectively, for levofloxa
cin and 0.6, 1.1, and 1.5 h respectively, for ciprofloxacin. The PA SM
Es observed demonstrate the superior activity of levofloxacin against
methicillin-susceptible or methicillin-resistant S. aureus. Although P
AEs were similar for the penicillin-susceptible and pencillin-resistan
t S. pneumoniae strains, the PA SME of levofloxacin at one-fourth the
MIC was longer for penicillin-resistant S. pneumoniae.